Michael Walsh is the Founder and Principal of Patient Advocacy Strategies and within this capacity oversees all aspects of the company’s direction and client strategy.
He has spent his entire career of 24 years within the life science industry, and calls upon this experience to offer strategic counsel and leadership to clients. Prior to establishing Patient Advocacy Strategies Michael has served in a multitude of escalating advocacy and management roles at Amgen, MedImmune, Biogen, InterMune, and Genentech. His work encompasses experience in a vast array of disease states from ultra rare to more common conditions.
He currently serves on the Board of Directors for the Prescription Process Advocacy Network, the OA Action Alliance, as a Corporator for Eagle Bank, and previously served on the Board for the MA March Of Dimes, Co-Chair of the MassBio Marketing & Communications Committee and the MassBio Patient Advocacy Task Force.